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ABSTRACT Previousmolecular dynamic simulations have reported elongation of the existing b-sheet in prion proteins. Detailed
examination has shown that these elongations do not extend beyond the proline residues ﬂanking these b-sheets. In addition,
proline has also been suggested to possess a possible structural role in preserving protein interaction sites by preventing invasion
of neighboring secondary structures. In this work, we have studied the possible structural role of the ﬂanking proline residues by
simulating mutant structures with alternate substitution of the proline residues with valine. Simulations showed a directional in-
hibition of elongation, with the elongation progressing in the direction of valine including evident inhibition of elongation by existing
proline residues. This suggests that the ﬂanking proline residues in prion proteins may have a containment role and would conﬁne
the b-sheet within a speciﬁc length.
INTRODUCTION
Prions are a transmissible agent consisting of an abnormal
isoform of the prion protein (PrP), designated PrPSC (1).
PrPSC (SC for scrapie) is derived from a posttranslational
conformational transformation (2,3) of the cellular isoform,
PrPC (C for cellular) (4,5). The term ‘‘prion’’ is a dyslexic
acronym (6) coined by Prusiner for ‘‘proteinaceous infec-
tious particle’’ to deﬁne a small proteinaceous infectious
particle that resists inactivation by procedures which modify
nucleic acids (7). According to the ‘‘protein only’’ hypoth-
esis, prion propagation involves a novel concept of trans-
mission by proteinaceous material alone, which is able to
convert other normal isoforms to itself in an autocatalytic
manner causing infection and disease proliferation without
the transmission of a nucleic acid genome. PrP is unique in
that it goes against two main dogmas in molecular biology.
First, PrP has shown that pathogens are able to replicate in
the absence of nucleic acids. Second, PrP deﬁes the ‘‘one
sequence, one conformation’’ dogma because the conforma-
tion of the normal PrP sequence can transform into a different
pathogenic conformation, either spontaneously or by asso-
ciation with repreexisting pathogenic material (8). Prion
diseases or transmissible spongiform encephalopathies are
characterized by spongiform degeneration and the accumu-
lation of PrPSC in the brain. Prion diseases can also be
grouped under the more general term of conformational dis-
eases such as a1-antitrypsin deﬁciency, sickle cell anemia,
and familial amyloid polyneuropathy as all these diseases
have comparable inherent conformational instability of a
speciﬁc protein that results in its deposition in the tissue of
the affected organism (9,10).
There are 15 proline residues in the human PrP structure,
with 12 residues in the ﬂexible N-terminus. The 12 proline
residues in the N-terminus are periodic and conformationally
stabilized by copper (11). The other three proline residues are
located within the globular domain of PrPC. The antiparallel
b-sheet consisting of strand S2 is ﬂanked at both ends by
Pro-158 and Pro-165, with the opposing strand S1 ﬂanked by
a single proline at position 137 (Fig. 1). Proline is an amino
acid that has a pyrrolidine ring structure that prevents
participation in the usual hydrogen bonding between NH and
CO groups of other amino acids. The presence of the ring
causes proline to be disfavored in b-sheet structure as its
f-angle is incompatible and it lacks one potential H-bond
donor (12). Consequently, this makes its occurrence in b-sheet
rare. In fact, the rare occurrences of proline in secondary
structure have led to the practice of systematically substitut-
ing proline in mutagenesis studies, thus becoming a practical
tool to identify segments involved in protein aggregation
(13). Proline residues are more frequently found in sharp
turns linking b-strands (b-bends), kinks in transmembrane
a-helices, at the edges of b-sheets or, most frequently, within
loops and disordered regions of proteins (13).
Previously, we have performed MD simulations at denatur-
ing temperatures, and residual structures have shown evidence
that suggested that the elongation of S1 and S2 in the PrP
is restricted and did not proceed beyond Pro-158 and Pro-
165 ﬂanking both sides of S2 and beyond Pro-137 on the
C-terminal end of S1 (14). Other MD simulations have also
shown similar restrictions (15–18) even at elevated temper-
atures (19). The zipper-like progression of sheet formation
could therefore be prevented by the presence of these proline
‘‘brackets’’.
A study has also shown that proline is the residue most
commonly found in the ﬂanking segments of protein-protein
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interaction sites (20). Examination of over 1600 protein-
protein interaction sites indicated that proline residues are
commonly found within these ﬂanking segments and the
probability of occurrence in ﬂanking segments is 2.5 times
greater than elsewhere in the structure (20). As a result,
proline brackets have been proposed to perform a structural
role in protecting the conformation and integrity of the
interaction site by blocking the ‘‘invasion’’ of neighboring
secondary structures (20). Investigation of the properties of
proline-delimited regions has also led to the discovery of the
L-type Ca21 channel binding site of calciseptine (21).
The presence of proline residues at the edge of the b-sheet
has also been proposed as a negative design feature to avoid
aggregation and essentially to serve as a capping mechanism
(22). A survey of all the prion structures available in the
Protein Data Bank (PDB) revealed that proline bracket is
present and that the secondary structure architecture of the
S2 strand is highly conserved in the different species, as ex-
pected from the high degree of sequence identity (Table 1).
This work follows our earlier observations regarding the
expansion of b-sheet (14) and examines if the existence of
proline residues ﬂanking b-strands’ S1 and S2 has a role in
restraining the zippering process of the b-strands, therefore
maintaining its length to a ﬁxed number of residues. Variants
with alternating proline substitutions have been used to
examine if speciﬁc proline residues play a distinct role in
restraining the b-sheet.
MATERIALS AND METHODS
The starting structure for all the simulations was based on the NMR structure
of the human PrP domain designated in PDB as 1QLX (23), which contains
the C-terminal globular structure of human prion consisting of residues 125–
228. The structure 1QLX was used as wild-type, and the variant structures
were constructed using Deep View (24) by alternate substitution of proline
with valine at position 135, 158, and 165 (Fig. 1), creating seven mutant var-
iants which were used for the simulations (Table 2).
The remainder of the structure is left unaltered. The disulphide bond
between H2 and H3 was left intact as previous work showed that it remains
oxidized in PrPSC and necessary for infectivity (25,26). All models were
solvated in a box of explicit simple point charge water molecules and simulated
using periodic boundary conditions and particle mesh Ewald summation that
have been shown to improve electrostatic interactions (27). Structures were
FIGURE 1 Ribbon diagram of S1 (sheet 1), S2 (sheet 2), and H1 (helix 1),
with proline indicated by its ring. The diagram shows only S1, S2, and H1,
with H2 (helix 2) and H3 (helix 3) omitted for clarity. The secondary
structures are presented with helices and sheets.
TABLE 1 Amino acid sequence alignment of the fragment 158–173 for the different species
PDB ID Species 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173
1QLX Human Y P N Q V Y Y R P M D E Y S N Q N
1AG2 Mouse Y P N Q V Y Y R P V D Q Y S N Q N
1B10 Hamster Y P N Q V Y Y R P V D Q Y N N Q N
1DWY Bovine Y P N Q V Y Y R P V D Q Y S N Q N
1UW3 Sheep Y P N Q V Y Y R P V D R Y S N Q N
1XYJ Cat Y P N Q V Y Y R P V D Q Y S N Q N
1XYQ Pig Y P N Q V Y Y R P V D Q Y S N Q N
1XYW Elk Y P N Q V Y Y R P V D Q Y N N Q N
1XYK Dog Y P N Q V Y Y R P V D Q Y N N Q S
1XU0 Frog M P N R V – Y R P M Y R G E E Y V
1U3M Chicken Y P N R V Y Y R D Y S S – – P V P
1U5L Turtle Y P N R V Y Y K E Y N D R – S V P
The table shows NMR determined structures deposited in the PDB. It uses human sequence numbering with ﬂanking proline residues underlined and b-sheet
assigned structure consisting of amino acid residues. VYY is highlighted in bold.
TABLE 2 Variants of proline/valine construct used in the
MD simulations
Variant 1QLX PPV PVV PVP VPP VVP VPV VVV
Res 135 P P P P V V V V
Res 158 P P V V P V P V
Res 165 P V V P P P V V
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minimized using 200 steps of the steepest descent method. Simulations were
performed using the GROMACS 3.1.4 package and the all-hydrogen func-
tion GROMOS96 (28). Simulations were carried out at 300 K and 500 K,
and isotropic pressure coupling was applied. All systems were equilibrated
for 200 ps of solute position restrained molecular dynamics (MD). Unre-
strained MD was performed on all variants for 2 ns with a LINCS algorithm
2-fs time step for each system. Simulations that showed a signiﬁcant increase
in b-sheet structure were repeated over a longer 10-ns timescale. Simula-
tions were performed at pH 7. All the resulting trajectories were analyzed
using GROMACS utilities. The Ca root mean-square deviations (RMSDs)
and Ca root mean-square ﬂuctuations (RMSFs) relative to the average MD
structure were calculated. The DSSP program was used to determine the
percentage of secondary structure throughout the simulations (29). Protein
structure images were created using PyMOL (30) and Protein Explorer (31).
RESULTS AND DISCUSSION
Structural deviations and ﬂuctuations
Fig. 2 shows the RMSD from the NMR structure as a
function of simulation time for the Ca atom in each variant.
Fig. 3 shows that the RMSF from the NMR structure is a
function of residue number for the Ca atom in each variant.
The MD simulation showed that all variants were stable
throughout the simulation. The Ca RMSD values for all eight
variants increased during the ﬁrst 0.1 ns before reaching a
plateau at 0.150.3 ns (Fig. 2). The RMSFs of all variants
showed that highest ﬂuctuations occurred in the N-terminus
and the loop between helices (H2 and H3) (Fig. 3), whereas
the globular domain containing H2 and H3 remains rel-
atively stable. Consequently, this created the groove pattern
observed in reported MD simulations (14,17,19,32,33). The
absence of rigid constraints imposed by proline residues on
the N-Ca rotation in mutated structures did not substantially
increase the ﬂuctuations of the global conformation.
b-sheet content
Fig. 4, a–h, shows the number of residues forming b-sheets
as a function of simulation time determined with DSSP. Only
two variants, VVV (Fig. 4 a) and PVV (Fig. 4 c), exhibited
an increase in the number of residues participating in the
b-sheet formation. MD simulation of VVV showed a discern-
ible pair-like addition of two residues at a time at 0.5 ns and
1.6 ns (Fig. 4 a), suggesting a zippering process (34). A two-
residue extension occurred with the addition of four partici-
pating residues at the end of the simulation. MD simulation
of PVV showed a similar but faster pair-like increase during
the ﬁrst 0.2 ns. However, the extension in PVV exhibited
higher ﬂuctuations than VVV. The rest of the variants did not
show a sustained increase in residue number and only showed
ﬂuctuations at around six residues (Fig. 4, b and d–h). The
wild-type structure PPP showed the biggest ﬂuctuations in
b-sheet content ranging between 0 and 7 residues (Fig. 4 g).
FIGURE 2 RMSDs of all proline var-
iants as a function of time for all proline
variants.
FIGURE 3 RMSFs of all proline variants
with residues numbered according to the
human prion residue sequence; blue bars
denote a-helices, red bars b-sheets in wild-
type structure; S1, sheet 1; S2, sheet 2; H1,
helix 1; H2, helix 2; H3, helix 3, and black
arrows indicate the position of proline
residues in the protein sequence.
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FIGURE 4 Number of residues forming b-sheets as a function of simulation time determined with DSSP during the simulation (a) VVV, (b) VPV, (c) PVV,
(d) PPV, (e) PVP, (f) VVP, (g) PPP, and (h) VPP.
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Structural evolutions: elongation of
existing b-sheets
Figs. 5, a–d, and 6, a–d, show the evolution of the secondary
structures during the MD simulation as determined by DSSP.
In all the simulations, the increase of b-sheets occurred
through the extension of existing secondary structure and not
by creation of new b-structures anywhere else in the protein
structure.
Analysis of the secondary structure evolution revealed
several interesting observations. The presence of the Pro-158
and Pro-165 ﬂanking S2 seems to hinder the elongation of
b-sheet S1 and S2, and its removal seems to induce b-sheet
elongation. In VVV and PVV where these two proline resi-
dues have been replaced, the elongation occurred in both
directions. In other variants, the expansion occurs away from
an existing proline residue, thus creating a directional pattern
(Fig. 7). The presence of Pro-137 residue did not prevent
sheet elongation. This is probably because Pro-137 is three
residues farther down the sequence and elongation may
therefore occur on a longer timescale. Previous MD simu-
lations have reported elongation of S1 and S2 (15,16,18,35–
37) where all elongation of S2 was limited to within the six
residues between Pro-158 and Pro-165.
Mechanism of elongation
The MD simulation trajectories for VVV, PVV, and PPP
were examined by superimposing sequential coordinate snap-
shots of structures to examine its conformational changes.
The trajectory of VVV showed low ﬂuctuations about the
secondary structure and did not exhibit any major departure
from the NMR structure. The reduced mobility of the resi-
dues Leu-125-Gly-126-Gly-127-Tyr-128 of the N-terminus
is evident by its movement into the globular structure as the
FIGURE 5 Secondary structure of
variants as a function of simulation
time determined by DSSP. The diagram
shows (a) VVV, (b) VVP, (c) VPV, and
(d) PVV variants. H1, H2, and H3
denote helices 1, 2, and 3. S1 and S2
denote sheet 1 and sheet 2. The color
guide denotes types of secondary struc-
ture.
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zippering process realigns it to elongate the b-sheet. The
ﬂuctuations are constrained by the alignment process of the
N-terminus, which results in the low RMSF range of 0.1–
0.25 nm. In contrast, the Leu-125-Gly-127-Gly-127-Tyr-128
residues of PPP exhibited higher mobility due to the absence
of the zippering and realignment process in VVV, as exem-
pliﬁed by the higher RMSF range of 0.10.5 nm. The
trajectory of PVV exhibits intermediate behavior with partial
zippering and alignment. The Leu-125-Gly-126-Gly-127-
Tyr-128 residues also showed reduced ﬂuctuations com-
pared to PPP. In contrast to the N-terminus, residues forming
segments between S1 and S2 that include H1 showed higher
mobility in VVV compared to PPP and PVV. These in-
creased ﬂuctuations could be attributed to the absence of
rigidity that Pro-137 residues imposed on the N-Ca rotation,
consequently limiting the plasticity of the same segment in
PVV and PPP. The global stability of the structure and
realignment of the N-terminus suggest that the elongation of
b-sheet occurs through the ability of valine to form hydrogen
bonding after substituting proline, thus allowing the zippering
process to continue.
Extended simulations
Extended MD simulations were performed to examine
structural stability over a longer simulation period. Three
variants—VVV, PVV, and PPP—and chicken prion 1U3M
were simulated. VVV and PVVwere selected, as both showed
an extended zippering of the b-sheet compared to the other
variants, and PPP is selected as a control representing the
wild-type structure. 1U3M was chosen as the chicken prion
structure (38) has a different proline trimer sequence at
position 151-165-176, with ;30% sequence identity, and is
expected to show different conformational behavior.
Fig. 8, a–d, shows the evolution of the secondary struc-
tures and Fig. 9, a–d, shows the b-sheets’ content of each
FIGURE 6 Secondary structure of
variants as a function of simulation
time determined with DSSP. The dia-
gram shows (a) VPP, (b) PVP, (c) PPV,
and (d) PPP variants. H1, H2, and H3
denote helices 1, 2, and 3. S1 and S2
denote sheet 1 and sheet 2. The color
guide denotes types of secondary struc-
ture.
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variant as determined by DSSP for (a) PVV, (b) PPP, (c)
1U5L, and (d) VVV, respectively. The result for PVV, PPP,
and VVV is similar to their initial runs where the increase of
b-sheets occurred through the extension of the existing
secondary structure and not by creation of new b-structures
anywhere else in the protein structure. The simulation is also
stable without any changes in the overall protein conforma-
tion. The Ca RMSD values for all three variants stabilized
after 0.3 ns and the Ca RMSF of all variants showed a similar
groove pattern signature observed in the 2-ns MD simulation
and to other reported MD simulations (14,17,19,32,33). The
PVV variant showed a 100% increase in the number of
residues participating in the b-sheet elongation to 13 resi-
dues similar to the initial 2-ns MD simulation (Fig. 9 a). The
longer simulation showed the b-sheet formation stabilizing
at 4.4 ns and showed similar elongation mechanism to the
earlier MD. The VVV variant also showed similar behavior
to the initial MD but with a higher degree of structural
ﬂuctuation in residues forming segments between S1 and S2
that include H1 compared to PVV. These larger ﬂuctuations
are exempliﬁed by the failure to recruit adjacent residues to
extend the b-sheet, thus limiting the residue participation to
eight amino acids (Fig. 9 d). In addition, the PPP variant also
behaved in a similar manner to the initial MD simulation
with the number of participating residues limited to between
six and nine (Fig. 9 b). The chicken prion also showed
similar global conformational behavior with the other three
variants (Fig. 8 c). The secondary structures were maintained
throughout the MD simulation but with larger ﬂuctuations.
The b-sheet content ﬂuctuated throughout the simulation,
with the number of residues forming b-sheets ﬂuctuating
between 8 and 10 residues, similar to the ranges shown by
VVV (Fig. 9 c). There was a temporary increase in the
number of residues participating in b-sheet formation between
1 ns and 2 ns via the formation of a turn at the N-terminal and
the creation of unstable triple-stranded b-sheets (Fig. 8 c).
CONCLUSIONS
MD simulation of proline-substituted structures showed that
removal of proline residues induces directional elongation of
the b-sheet. The extended 10-ns MD simulations have also
shown that the b-sheet structure is stable for certain variant
(PVV) but not VVV. This suggests that substituting all of the
proline residues would reduce structural rigidity and increase
ﬂuctuations, therefore decreasing the propensity for adjacent
strands to align and form b-sheets. It also showed that the
wild-type variant (PPP) did not increase the b-sheet content
at the end of the simulation. Simulation of the chicken prion
did not show an increase even though the proline brackets
were farther apart than the human prion, suggesting other
factors might contribute to the failure of the b-sheet to
expand. This is not surprising as the low sequence identity
with human PrP might provide altered dynamics compared
to mammalian-derived PrPs. Further work needs to be done
to study the MD signature of chicken as well as other
nonmammalian prions such as those of turtles and frogs (38).
The elongation occurred via a zippering process that is
discernible by a pairing pattern caused by sequential recruit-
ment of residues in pairs. Therefore, when the zipper-like
process is halted by the ﬂanking proline in the structure,
this suggests that proline residues act as a steric barrier by
restricting the number of residues to six within the proline
bracket of Pro-158 and Pro-165. Interestingly, the six-residue
FIGURE 7 Schematic diagram of the direction of
the b-sheet expansion. The diagram shows the sche-
matic of b-sheet expansion of all proline variants. The
antiparallel b-sheets are denoted by a pair of black
boxes, the direction of the polypeptide is denoted by
the black arrow, and the presence and direction of
expansion are in gray arrows.
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length is near the intrinsic limit of conformational stability in
antiparallel b-sheet. Studies have shown that at least for
some antiparallel sequences, the conformational stability
increases with strand length to a maximum of seven residues
(39). The proline bracket has also been shown to conﬁne the
secondary structures within its boundary even in elevated
temperature. In contrast, the lone proline at residue 137 does
not play a role in this bracket but seems to contribute only to
the structural rigidity of the segment between S1 and S2. If
the presence of the proline brackets is instrumental in deter-
mining and maintaining the length of the b-sheet to a ﬁxed
number of residues, there is a possibility that the length of
additional b-sheet propagated by the residues 90–124 of the
ﬂexible N-terminus (17) must not exceed a certain length of
the seed strand (S2). Models of possible prion protoﬁbrils
created using electron crystallography data showed preser-
vation of b-sheet length within the proline bracket, thus
reinforcing its possible role in determining b-sheet length
(40,41). Analysis of sequence evolutionary conservation in
27 mammalian and 9 avian PrPC has shown that the proline
bracket segment PNQVYYRP is highly conserved (42). In
addition, the segment XPNXVY that contains Pro-158 has a
higher than average sequence conservation and appears to be
needed for the stability of the ‘‘PrP-fold’’ (38). Experimen-
tally, studies have shown that the existence of proline residues
plays a signiﬁcant role in protein conformational stability
FIGURE 8 Secondary structure as a
function of simulation time determined
with DSSP during the simulation: (a)
PVV, (b) PPP, (c) 1U3M, and (d) VVV;
S1, sheet 1; S2, sheet 2; H1, helix 1;
H2, helix 2; H3, helix 3. The color
guide designates types of secondary
structure.
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(43,44) and function (45). However, this unique role is
attributed to the limited conformation that proline residues
confer on the N-Ca rotation and not because of its inability to
form b-sheet hydrogen bonding. In addition, this is the ﬁrst
time, to our knowledge, that MD simulations have shown the
role of proline in maintaining the secondary structure in such
a manner. Nevertheless, further work needs to be done by
conducting a survey of existing protein structures to examine
if this phenomenon applies to other similarly structured
proteins.
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